NCT02339064 - Infusion of Apomorphine: Long-term Safety Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2025

Conditions

Idiopathic Parkinson's Disease

Interventions

DRUG

apomorphine infusion

Treatment with apomorphine provided by continuous subcutaneous infusion using a portable external electronic pump device

Trial Locations (18)

12208

Albany

19107

Philadelphia

30329

Atlanta

30912

Augusta

33486

Boca Raton

45219

Cincinnati

48322

West Bloomfield

60611

Chicago

60612

Chicago

66160

Kansas City

80045

Aurora

80113

Englewood

85013

Phoenix

90033

Los Angeles

90095

Los Angeles

92354

Loma Linda

97239

Portland VA Medical Center, Portland

98034

Kirkland

All Listed Sponsors

lead

MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals

INDUSTRY